Recently, the academic monograph "Typical Case Collection of Selective Internal Radiation Therapy with Yttrium-90 [90Y] Microspheres for Malignant Liver Tumors", edited by Professor Cao Mingrong, the chief expert of the Yttrium-90 treatment MDT team for hepatobiliary tumors at our hospital, has been successfully published.

With continuous innovation in medical technology and the accumulation of clinical experience, the selective internal radiation therapy technique with Yttrium-90 [90Y] microspheres has gained wider promotion and application domestically, benefiting numerous patients. However, due to the high qualifications required for hospitals and the expertise of specialists, many hospitals are still unable to offer this treatment, and many doctors are still not familiar with it.

This book, compiled by hospitals and experts who have implemented this treatment, reviews and summarizes the experiences of Yttrium-90 therapy, collecting typical cases into a reference book. It is intended for healthcare workers dedicated to conquering liver cancer, as well as liver cancer patients and their families. The book aims to further raise awareness of this technology in both the medical field and society at large, offering more hope of a cure for patients with advanced liver cancer.

Expert Introduction: Professor Cao Mingrong

Chief Physician, Professor, Doctoral Supervisor

Chief Expert of the Yttrium-90 Treatment MDT Team for Hepatobiliary Tumors at Guangzhou Royal Lee Cancer Hospital

Director of the Yttrium-90 Liver Tumor Treatment Center at the First Affiliated Hospital of Jinan University

Renowned Physician of Lingnan, First "Yangcheng Good Doctor" Award Winner

Academic Positions:

• Vice Chairman of the Tumor Internal Radiation Medicine Professional Committee of the China Medical Education Association

• Executive Director of the Guangdong Anti-Cancer Association

• Chairman of the MDT Professional Group of the Hepatobiliary Pancreatic Surgery Physician Work Committee of the Guangdong Medical Doctor Association

• Vice Chairman of the Minimally Invasive Professional Committee of the Hepatobiliary Pancreatic Surgery of the Guangdong Health Management Association

• Vice Chairman of the Pancreatic Disease Professional Committee of the Guangdong Health Management Association

• Vice Chairman of the Hepatobiliary Disease Professional Committee of the Guangdong Health Management Association

• Vice Chairman of the Bile and Pancreatic Professional Committee of the Guangdong Liver Disease Society

• Vice Chairman of the Portal Hypertension Management Subcommittee of the Guangdong Medical Industry Association

• Vice Chairman of the Minimally Invasive Professional Physicians Subcommittee of the Guangzhou Medical Doctor Association

• Consultant of the Metastatic Liver Cancer Professional Committee of the Guangdong Primary Medicine Association

• Member of the Hepatobiliary Pancreatic MDT Professional Committee of the Chinese Branch of the International Hepato-Pancreato-Biliary Association

• Member of the Laparoscopic Liver Resection Development and Promotion Expert Committee of the Chinese Branch of the International Hepato-Pancreato-Biliary Association

• Member of the Biliary Tumor Professional Committee of the Chinese Branch of the International Hepato-Pancreato-Biliary Association

• Executive Member of the Hepatocellular Carcinoma Committee of the Guangdong Medical Association

• Standing Member of the Guangdong Hepatocellular Carcinoma Professional Committee of the Chinese Anti-Cancer Association

• Standing Member of the Biliary Tumor Professional Committee of the Chinese Anti-Cancer Association, Guangdong Branch

• Standing Member of the Thermal Therapy Professional Committee of the Guangdong Anti-Cancer Association

• Executive Director of the Guangdong Hepatobiliary and Biliary Tract Stone Alliance of the Guangdong Health Management Association

• Standing Member of the Hepatobiliary Pancreatic Surgery Physician Work Committee of the Guangdong Medical Doctor Association

• Standing Member of the Hepatobiliary Pancreatic Surgery Professional Committee of the Guangdong Medical Association

• Editorial Board Member of Lingnan Modern Clinical Surgery Journal

• Editorial Board Member of Digestive Surgery Journal

• Selected as an Advanced Role Model in Industry Conduct Construction by the Guangdong Provincial Health System in 2001

Areas of Expertise:

Precise clinical evaluation of Yttrium-90 treatment for liver cancer, quality control in the entire management of Yttrium-90 therapy, downstaging and conversion surgery after Yttrium-90 therapy, bridge therapy for liver transplantation with Yttrium-90, and the clinical application of Yttrium-90 microspheres in the conversion therapy and palliative care of metastatic liver cancer and intrahepatic cholangiocarcinoma. He also guides the implementation of multidisciplinary treatment (MDT) for liver cancer.

At Guangzhou Royal Lee Cancer Hospital, the hepatobiliary surgery, minimally invasive intervention, and nuclear medicine departments have established a multidisciplinary expert team for the clinical treatment of malignant liver tumors using Yttrium-90 microspheres. The hospital has obtained the necessary radiation therapy licenses, making it one of the few institutions in the country capable of standardizing this advanced technology. The hospital has successfully performed multiple Yttrium-90 liver cancer surgeries, bringing new hope to liver cancer patients.